Ramadan Fasting Improves Health‐Related Quality of Life in Patients With Secondary Adrenal Insufficiency: A Prospective Interventional Case‐Control Study
Clinical Endocrinology · 2025
DOI: 10.1111/cen.15286 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Mariam Mabrouk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta University Hospital, Tunis, Tunisia. Hauptthemen laut MEDLINE: Adrenal Insufficiency, Fasting, Islam, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
Intermittent fasting (IF) exposes patients with adrenal insufficiency (AI) to complications related to undertreatment. We aimed to determine the effect of IF during Ramadan on the quality of life of patients with secondary adrenal insufficiency (SAI) compared to healthy controls. Subjects and Methods It is a prospective case‐control study conducted at the Department of Endocrinology of La Rabta University Hospital in Tunisia. Fifty patients with SAI and 100 age‐, sex‐ and body mass index‐matched controls were enrolled and followed up throughout Ramadan 2023. All participants answered the Addison's disease quality of life questionnaire (AddiQoL) before Ramadan and during the third week of fasting.
Results
There were 33 women and 17 men, median age: 43 years (IQR: 34–55), median duration of SAI: 7.5 years (IQR: 4–12.5), treated with hydrocortisone at a median dose of 0.24 mg/kg/day (IQR: 0.20–0.27). Before Ramadan, there was no significant difference between patients and controls in the global AddiQoL score, fatigue score, and emotional sphere score (89 vs. 93, p = 0.196; 24 vs. 24, p = 0.354, and 24 vs. 25, p = 0.536, respectively). The score of AI symptoms was altered in patients (27 vs. 30, p = 0.021). During fasting, the global AddiQoL score (8.2% vs. 0%, p = 0.005), the fatigue score (8% vs. −1.7%, p = 0.003), the emotional sphere score (4.2% vs. 0%, p = 0.009), and the AI symptoms' score (9.1% vs. 0%, p = 0.017) improved in patients compared to controls.
Conclusion
Ramadan fasting improved the quality of life in SAI patients by reducing fatigue, emotional stress, and AI symptoms. Trial Registration Registered on ‘ClinicalTrials.gov’ under the identifier ID: NCT05827965.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta University Hospital, Tunis, Tunisia.
ORCID-Profile: Ibtissem Oueslati, Meriem Yazidi
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Mabrouk, M., Chihaoui, M., Sta, J., Slimane, C. B., Oueslati, I., Yazidi, M., & Chaker, F. (2025). Ramadan Fasting Improves Health‐Related Quality of Life in Patients With Secondary Adrenal Insufficiency: A Prospective Interventional Case‐Control Study. Clinical Endocrinology. https://doi.org/10.1111/cen.15286
Vancouver
Mabrouk M, Chihaoui M, Sta J, Slimane CB, Oueslati I, Yazidi M, et al. Ramadan Fasting Improves Health‐Related Quality of Life in Patients With Secondary Adrenal Insufficiency: A Prospective Interventional Case‐Control Study. Clinical Endocrinology. 2025. doi:10.1111/cen.15286
BibTeX
@article{Mabrouk2025,
author = {Mabrouk, Mariam and Chihaoui, Melika and Sta, Jameleddine and Slimane, Chayma Belhadj and Oueslati, Ibtissem and Yazidi, Meriem and Chaker, Fatma},
title = {Ramadan Fasting Improves Health‐Related Quality of Life in Patients With Secondary Adrenal Insufficiency: A Prospective Interventional Case‐Control Study},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15286}
}
EUVIMED